Literature DB >> 28214380

Application of the MechPeff model to predict passive effective intestinal permeability in the different regions of the rodent small intestine and colon.

D Pade1, M Jamei1, A Rostami-Hodjegan1,2, D B Turner1.   

Abstract

A major component of physiologically based pharmacokinetic (PBPK) models is the prediction of the rate and extent of absorption of orally dosed drugs for which knowledge of effective passive intestinal permeability (Peff ) is essential. Single-pass intestinal perfusion (SPIP) studies are used to establish effective permeability in vivo but are difficult to perform in rodents, while mechanistic models to predict drug Peff in rat and mouse have not been published. This work evaluates the predictive performance of the 'MechPeff' model to predict Peff in the rodent intestine based upon knowledge of regional gut physiology and drug-specific physicochemical parameters. The 'MechPeff' model, built-in to the Simcyp Rat and Mouse Simulators, predicts transcellular, paracellular and mucus layer permeabilities and combines these to give the overall Peff . The jejunal and/or ileal Peff was predicted for 12 (4) acidic, 13 (12) basic, 10 (8) neutral and 2 (0) ampholytic drugs in the rat (mouse), spanning a wide range of MW and logPo:w , and compared with experimental Peff obtained using SPIP. A key input is the intrinsic transcellular permeability (Ptrans,0 ) which can be derived from modelling of appropriate in vitro permeability experiments or predicted from physicochemical properties. The Peff predictions were reasonably good when experimentally derived Ptrans,0 was used; from 42 Peff,rat values, 24 (57%) were within 3-fold, and of 19 Peff,mouse values, 12 (63%) were within 3-fold, of observed Peff . Considering the lack of alternative models to predict Peff in preclinical species, and the minimal drug-specific inputs required, this model provides a valuable tool within drug discovery and development programmes.
Copyright © 2017 John Wiley & Sons, Ltd. Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  MechPeff; bile salts; gut morphology; mechanistic prediction; rodent intestinal permeability

Mesh:

Substances:

Year:  2017        PMID: 28214380     DOI: 10.1002/bdd.2072

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  10 in total

1.  Preincubation With Everolimus and Sirolimus Reduces Organic Anion-Transporting Polypeptide (OATP)1B1- and 1B3-Mediated Transport Independently of mTOR Kinase Inhibition: Implication in Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions.

Authors:  Taleah Farasyn; Alexandra Crowe; Oliver Hatley; Sibylle Neuhoff; Khondoker Alam; Jean Kanyo; TuKiet T Lam; Kai Ding; Wei Yue
Journal:  J Pharm Sci       Date:  2019-04-30       Impact factor: 3.534

2.  Physiologically Based Pharmacokinetic Modeling of Fimasartan, Amlodipine, and Hydrochlorothiazide for the Investigation of Drug-Drug Interaction Potentials.

Authors:  Su-Jin Rhee; Hyun A Lee; Soyoung Lee; Eunwoo Kim; Inseung Jeon; Im-Sook Song; Kyung-Sang Yu
Journal:  Pharm Res       Date:  2018-10-15       Impact factor: 4.200

3.  A Mechanistic Absorption and Disposition Model of Ritonavir to Predict Exposure and Drug-Drug Interaction Potential of CYP3A4/5 and CYP2D6 Substrates.

Authors:  Sumit Arora; Amita Pansari; Peter J Kilford; Masoud Jamei; David B Turner; Iain Gardner
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2022-04-29       Impact factor: 2.441

4.  Physiologically-Based Pharmacokinetic Models of CYP2D6 Substrate and Inhibitors Nebivolol, Cinacalcet and Mirabegron to Simulate Drug-Drug Interactions.

Authors:  Peter Kilford; Nika Khoshaein; Roz Southall; Iain Gardner
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2022-07-15       Impact factor: 2.569

5.  Application of a Physiologically Based Pharmacokinetic Approach to Predict Theophylline Pharmacokinetics Using Virtual Non-Pregnant, Pregnant, Fetal, Breast-Feeding, and Neonatal Populations.

Authors:  Khaled Abduljalil; Iain Gardner; Masoud Jamei
Journal:  Front Pediatr       Date:  2022-05-12       Impact factor: 3.569

6.  Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator.

Authors:  Udoamaka Ezuruike; Mian Zhang; Amita Pansari; Mailys De Sousa Mendes; Xian Pan; Sibylle Neuhoff; Iain Gardner
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-04-18

7.  Assessing Potential Drug-Drug Interactions Between Dabigatran Etexilate and a P-Glycoprotein Inhibitor in Renal Impairment Populations Using Physiologically Based Pharmacokinetic Modeling.

Authors:  Kosuke Doki; Sibylle Neuhoff; Amin Rostami-Hodjegan; Masato Homma
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2019-02

8.  Lost in modelling and simulation?

Authors:  Kiyohiko Sugano
Journal:  ADMET DMPK       Date:  2021-03-22

9.  Prediction of the Pharmacokinetics of Pravastatin as an OATP Substrate Using Plateable Human Hepatocytes With Human Plasma Data and PBPK Modeling.

Authors:  Jialin Mao; Utkarsh Doshi; Matthew Wright; Cornelis E C A Hop; Albert P Li; Yuan Chen
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2018-02-13

10.  New insights into the mechanisms underlying 5-fluorouracil-induced intestinal toxicity based on transcriptomic and metabolomic responses in human intestinal organoids.

Authors:  Daniela Rodrigues; Terezinha de Souza; Luke Coyle; Matteo Di Piazza; Bram Herpers; Sofia Ferreira; Mian Zhang; Johanna Vappiani; Daniel C Sévin; Attila Gabor; Anthony Lynch; Seung-Wook Chung; Julio Saez-Rodriguez; Danyel G J Jennen; Jos C S Kleinjans; Theo M de Kok
Journal:  Arch Toxicol       Date:  2021-06-20       Impact factor: 5.153

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.